- Goldhaber SZ, Visani L, De Rosa M. (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353:1386–1389 [CrossRef] [PubMed] [Google Scholar]
- Kasper W, Konstantinides S, Geibel A, et al (1997) Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 30:1165–1171 [CrossRef] [PubMed] [Google Scholar]
- Buller HR, Prins MH, Lensin AW, et al (2012) Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 366:1287–1297 [CrossRef] [PubMed] [Google Scholar]
- Konstantinides SV, Torbicki A, Agnelli G, et al (2014) 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35:3033–3069 [CrossRef] [PubMed] [Google Scholar]
- Jimenez D, Kopecna D, Tapson V, et al (2014) Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism. Am J Respir Crit Care Med 189:718–726 [CrossRef] [PubMed] [Google Scholar]
- Sanchez O, Trinquart L, Caille V, et al (2010) Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study. Am J Respir Crit Care Med 181:168–173 [CrossRef] [PubMed] [Google Scholar]
- Lankeit M, Jimenez D, Kostrubiec M, et al (2014) Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism. Eur Respir J 43:1669–1677 [CrossRef] [PubMed] [Google Scholar]
- Aujesky D, Obrosky DS, Stone RA, et al (2005) Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 172:1041–1046 [CrossRef] [PubMed] [Google Scholar]
- Jimenez D, Aujesky D, Moores L, et al (2010) Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 170:1383–1389 [CrossRef] [PubMed] [Google Scholar]
- Dalla-Volta S, Palla A, Santolicandro A, et al (1992) PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol 20:520–526 [CrossRef] [PubMed] [Google Scholar]
- Goldhaber SZ, Haire WD, Feldstein ML, et al (1993) Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 341:507–511 [CrossRef] [PubMed] [Google Scholar]
- 1973) The urokinase pulmonary embolism trial. A national cooperative study. Circulation 47:II1–II108. [CrossRef] [PubMed] [Google Scholar]
- 1990) Tissue plasminogen activator for the treatment of acute pulmonary embolism. A collaborative study by the PIOPED Investigators. Chest 97:528–533. [CrossRef] [PubMed] [Google Scholar]
- Dotter CTSA, Rösch J, Poter JM. (1979) Streptokinase and heparin in the treatment of pulmonary embolism: a randomized comparison. Vascular Surgery 13:42–52 [CrossRef] [Google Scholar]
- Levine M, Hirsh J, Weitz J, et al (1990) A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest 98:1473–1479 [CrossRef] [PubMed] [Google Scholar]
- Jerjes-Sanchez C, Ramirez-Rivera A, de Lourdes Garcia M, et al (1995) Streptokinase and Heparin versus Heparin Alone in Massive Pulmonary Embolism: A Randomized Controlled Trial. J Thromb Thrombolysis 2:227–229 [CrossRef] [PubMed] [Google Scholar]
- Konstantinides S, Geibel A, Heusel G, et al (2002) Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 347:1143–1150 [CrossRef] [PubMed] [Google Scholar]
- Ly B, Arnesen H, Eie H, Hol R. (1978) A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism. Acta Med Scand 203:465–470 [CrossRef] [PubMed] [Google Scholar]
- Marini C, Di Ricco G, Rossi G, et al (1988) Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial. Respiration 54:162–173 [CrossRef] [PubMed] [Google Scholar]
- Tibbutt DA, Davies JA, Anderson JA, et al (1974) Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonay embolism. Br Med J 1:343–347 [CrossRef] [PubMed] [Google Scholar]
- Wan S, Quinlan DJ, Agnelli G, Eikelboom JW. (2004) Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation 110:744–749 [CrossRef] [PubMed] [Google Scholar]
- Konstantinides S, Geibel A, Olschewski M, et al (1997) Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation 96:882–888 [CrossRef] [PubMed] [Google Scholar]
- Riera-Mestre A, Jimenez D, Muriel A, et al (2012) Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism. J Thromb Haemost 10:751–759 [CrossRef] [PubMed] [Google Scholar]
- Meyer GVE, Danays T, Agnelli G, et al (2014) Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 370:1402–1411 [CrossRef] [PubMed] [Google Scholar]
- Kline JA, Nordenholz KE, Courtney DM, et al (2014) Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial. J Thromb Haemost 12:459–468 [CrossRef] [PubMed] [Google Scholar]
- Sharifi M, Bay C, Skrocki L, et al (2013) Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” Trial). Am J Cardiol 111:273–277 [CrossRef] [PubMed] [Google Scholar]
- Marti C, John G, Konstantinides S, et al (2015) Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J (pii: ehu218. [Epub ahead of print]). [Google Scholar]
- Kearon C, Akl EA, Comerota AJ, et al (2012) Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e419S–e494S [CrossRef] [PubMed] [Google Scholar]
- Becattini C, Agnelli G, Salvi A, et al (2010) Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism. Thromb Res 125:e82–e86. doi:10.1016/j.thromres.2009.09.017. Epub 2009 Oct 14. [CrossRef] [PubMed] [Google Scholar]
Free Access
| Issue |
Réanimation
Volume 24, Number 2, Mars 2015
Cardiovasculaire
|
|
|---|---|---|
| Page(s) | 98 - 103 | |
| Section | Mise Au Point / Update | |
| DOI | https://doi.org/10.1007/s13546-015-1039-5 | |
| Published online | 27 February 2015 | |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.